Future JVsI have appreciated the various posts regarding how TLT could secure funds to complete the Phase 2 NMIBC evaluation and beyond, particularly possible investments from a big Pharma company. Likewise, I also hear those who caution the participation of big Pharma who would want to minimize TLT’s competitive impact. Some time ago, I recall posters suggesting that the company’s collaborations could come just as easily from a Big Tech company as it could from Pharma. As time unfolds I find this possibility even more provocative. TLT’s expertise has a wide umbrella. Would a mega tech company, ie IBM or GE, both whom are struggling, wish to redirect and redefine themselves by moving in to this specific healthcare space by partnering with a company like TLT. Who knows? Just thought I’d offer this for discussion.
Thanks.